Currency played an important role in Q2, with US dollar, Japanese yen and euro appreciating vis-a-vis the Indian rupee, while the Brazilian real, South African rand and Russian ruble depreciating against rupee.
Large pharmaceutical firms feel that if the quality parameters and assurance levels are brought up to the level of branded generics, then Jan Aushadhi medicines would find it difficult to retain their affordability.
Some of the proposals (for example trade margin calculation for imported medical devices) were not approved by the PMO and were sent back for revisions.
This is not the first time Gujarat Cooperative Milk Marketing Federation that owns brand Amul has chosen an unconventional method to protect its brand.
NCLT allows Shivinder to withdraw petition against his brother Malvinder. Final decision to be taken by family members in their presence.
Sources said she had stopped eating for the past few days and had constantly been making calls and sending emails to the two brothers.
Once the patients are identified, the government will decide on the quantum of compensation in each case and then approach J&J for claim settlement.
Rough estimates show that at a rate of Rs 1 crore per hospital bed, the investment in India alone would be around Rs 2,000 crore
Some of the popular brands that would be impacted include Phensedyl (Abbott), Tixylix (Abbott), Gluconorm PG (Lupin), Ascoril D (Glenmark), Solvin Cold (Ipca), D Cold Total (Paras Pharma).
In its investor presentation, IHH said it wanted to develop Fortis into a market leader.
Experts believe the move will have little impact given limited production of generic drugs and authority of doctors in prescribing medicines.
In May, price growth for drugs was in negative territory at (-)1 per cent
While farmers in Gujarat are rejecting the compensation package, farmers in Maharashtra say they do not wish to part with their land for a project that largely benefits Gujarat.
Their offer values Fortis at over Rs 9,000 crore, or around Rs 172 per share.
A recent report has suggested that future patent expires in the cardiac and anti-diabetes space would form a good opportunity for smaller firms, given their franchise in these segments.
In first 9 months of FY18, scooter sales grew by 18.5%, the number may jump further as more women join workforce
The procedure, however, would cost around Rs 75,000-100,000 more than conventional angioplasty.
Triumph's portfolio includes high-powered bikes such as the Daytona 200, Rocket III, SuperSports Daytona 675R and Tiger 800, apart from its iconic Bonneville family.
'I fight for anyone who is poor, marginalised or victimised.' 'If a Dalit factory owner is inflicting atrocities on his Brahmin worker, then I will fight for the poor Brahmin.'
The chief minister is not being hailed as the leader who led the party to a victory in the state.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances